LY-4170156

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY-4170156, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]